Resverlogix Corp.

SF.....But why is it that Resverlogix seems to raise more questions than providing answers to its shareholders. And why would they even allow the sale of RVX-208 to potential competitors and not address the issue on the MD&A. This makes no sense whatsoever. How much revenue could this sort of behavior by Resverlogix generate. A tuppence at best? 

Is this typical in the biomedical industry to sell precious assets to whomever? For example, does BTI also allows the sale of its molecule for the same reason?

I doubt it. 

Koo